background logo image
Episode 139

Taper Down Slowly: A Beginners Guide to Psychiatric Drug Tapering (Part 1)

Listen, Watch & Subscribe on:

Watch

Taper Down Slowly: A Beginners Guide to Psychiatric Drug Tapering (Part 1)

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

About the guest

Georgia Ede, MD

Georgia Ede, MD

Psychiatrist

Georgia Ede, MD

Psychiatrist

Dr. Georgia Ede is a Harvard-trained psychiatrist specializing in nutritional and metabolic psychiatry. She has used ketogenic diets to help her patients for over two decades. She created the first CME course training physicians in the use of ketogenic therapy as mental illness treatment. She educates the public about nutrition science, metabolism, and mental health through her international speaking engagements, website, and her first book: Change Your Diet, Change Your Mind.
Learn more about Georgia

Key Highlights

  • Most prescribers are trained to start psychiatric medications, but receive little to no formal training on safely tapering or deprescribing them, which can increase risk for patients if done incorrectly.
  • Tapering means gradually reducing a dose; deprescribing means tapering with the goal of reaching zero. Not everyone’s goal should be zero, and the right endpoint depends on the individual’s situation and definition of “treatment success.”
  • The brain adapts to psychiatric medications through homeostasis, changing receptors and signaling over time. This adaptation can make medications lose effectiveness and can also make dose reductions harder if done too quickly.
  • Withdrawal can be mistaken for relapse. Two key clues help differentiate them: withdrawal often starts within days of a dose change and may include symptoms not typical of the original condition (for example dizziness, flu-like symptoms, nightmares, sweating, “brain zaps”).
  • Withdrawal risk varies by medication class. SSRIs and SNRIs commonly cause discontinuation symptoms (including “brain zaps” and flu-like symptoms), while benzodiazepines and some anticonvulsants can cause rebound over-arousal and, in some cases, withdrawal seizures if reduced too fast.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

Keto and Psych Meds
Page

Keto and Psych Meds

Read more

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)
Podcast

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)

In part two of Metabolic Mind’s series on treatment resistant depression, Dr. Bret Scher and psychiatrist Dr. Georgia Ede review the leading next step treatment options beyond standard antidepressants. They discuss neurostimulation therapies like ECT, transcranial magnetic stimulation, and vagus nerve stimulation, along with rapid acting approaches such as ketamine, FDA approved esketamine (Spravato), and psilocybin. Learn how these treatments differ in effectiveness, session requirements, side effects, cost, and accessibility, and why response prediction remains difficult. The episode also previews part three, focused on lifestyle and metabolic interventions including diet, exercise, and other foundational strategies that may address root causes of depression.

Learn more

The Truth About Treatment Resistant Depression: Part Three (Nutrition and Lifestyle)
Podcast

The Truth About Treatment Resistant Depression: Part Three (Nutrition and Lifestyle)

In Part 3 of Metabolic Mind’s series on treatment-resistant depression, psychiatrist Dr. Georgia Ede and host Dr. Bret Scher explore how lifestyle interventions, especially nutrition, can powerfully affect mood and brain function. They discuss the connection between metabolic health and depression, why brain glucose processing may be impaired in treatment-resistant cases, and how ketogenic therapy can provide ketones as an alternative fuel for the brain. Learn practical strategies for exercise, sleep and circadian rhythm support, and the key medical tests that can help identify insulin resistance, plus why addressing potentially reversible root causes can restore hope and expand treatment options.

Learn more

Safe Tapering Practices for Anti-Depressants with Dr. Mark Horowitz
Podcast

Safe Tapering Practices for Anti-Depressants with Dr. Mark Horowitz

Deprescribing expert Dr. Mark Horowitz explains why psychiatric-med withdrawal is so often mistaken for relapse, how short-trial guidelines mislead clinicians, and the safer “hyperbolic” taper that uses liquids/compounding to make tiny final cuts. Learn practical signs of withdrawal vs. recurrence, what can buffer symptoms, who should (and shouldn’t) come off, and where to find evidence-based support.

Learn more

Keto and Psych Meds
Page

Keto and Psych Meds

Read more

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)
Podcast

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)

In part two of Metabolic Mind’s series on treatment resistant depression, Dr. Bret Scher and psychiatrist Dr. Georgia Ede review the leading next step treatment options beyond standard antidepressants. They discuss neurostimulation therapies like ECT, transcranial magnetic stimulation, and vagus nerve stimulation, along with rapid acting approaches such as ketamine, FDA approved esketamine (Spravato), and psilocybin. Learn how these treatments differ in effectiveness, session requirements, side effects, cost, and accessibility, and why response prediction remains difficult. The episode also previews part three, focused on lifestyle and metabolic interventions including diet, exercise, and other foundational strategies that may address root causes of depression.

Learn more

The Truth About Treatment Resistant Depression: Part Three (Nutrition and Lifestyle)
Podcast

The Truth About Treatment Resistant Depression: Part Three (Nutrition and Lifestyle)

In Part 3 of Metabolic Mind’s series on treatment-resistant depression, psychiatrist Dr. Georgia Ede and host Dr. Bret Scher explore how lifestyle interventions, especially nutrition, can powerfully affect mood and brain function. They discuss the connection between metabolic health and depression, why brain glucose processing may be impaired in treatment-resistant cases, and how ketogenic therapy can provide ketones as an alternative fuel for the brain. Learn practical strategies for exercise, sleep and circadian rhythm support, and the key medical tests that can help identify insulin resistance, plus why addressing potentially reversible root causes can restore hope and expand treatment options.

Learn more

Safe Tapering Practices for Anti-Depressants with Dr. Mark Horowitz
Podcast

Safe Tapering Practices for Anti-Depressants with Dr. Mark Horowitz

Deprescribing expert Dr. Mark Horowitz explains why psychiatric-med withdrawal is so often mistaken for relapse, how short-trial guidelines mislead clinicians, and the safer “hyperbolic” taper that uses liquids/compounding to make tiny final cuts. Learn practical signs of withdrawal vs. recurrence, what can buffer symptoms, who should (and shouldn’t) come off, and where to find evidence-based support.

Learn more